#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Prostate cancer Obesity Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Non-small cell lung cancer metastatic Dermatitis atopic Malignant melanoma Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stargardt's disease Gastrointestinal disorder Rhabdomyosarcoma Gastrointestinal neuroendocrine tumour Necrotising enterocolitis neonatal Liver abscess Thrombocytosis Follicle centre lymphoma follicular grade I, II – III Hyperchylomicronaemia Systemic candida HER2 gene amplification Immunodeficiency congenital Ovarian epithelial cancer Chronic myelomonocytic leukaemia Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Life with Disease Mucopolysaccharidosis II – Trials in Disease Mantle cell lymphoma stage IV – Trials in Disease Primary immunodeficiency syndrome – Diagnostics Testicular leiomyosarcoma – Diagnostics IgA nephropathy – Diagnostics Langerhans’ cell histiocytosis – Diagnostics Testicular leiomyosarcoma – Treatment Proteus syndrome – Treatment Congenital nephrogenic diabetes insipidus – Treatment More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    S227928 Spesolimab Imipenem Dextromethorphan Hydrobromide Lisdexamfetamine Dimesylate Pembrolizumab Trimetazidine Dihydrochloride Alxn1850 AVTX-009 Hypromellose Rimegepant Clebopride Hydrogen Maleate Propafenone Hydrochloride Trametinib Dimethyl Sulfoxide Treosulfan Vosoritide Dexamethasone Ph. Eur. Patritumab Deruxtecan Tanimilast Keto-Leucine Calcium More therapies…

    Learn about Your Condition

    Supranuclear palsy Tumour of ampulla of Vater Microvillous inclusion disease Pulmonary congestion Graft versus host disease Meningococcal infection Synovial sarcoma recurrent Low cardiac output syndrome Adenocarcinoma pancreas Peripheral spondyloarthritis B-cell lymphoma Pneumonia External cephalic version Infertility Cholangitis sclerosing More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Tibulizumab to Treat Adults with Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated diseases:
    • Hidradenitis
    Germany Hungary Poland Spain

  • Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

    Not recruiting

    3 1 1
    Investigated diseases:
    • Adenocarcinoma gastric
    • Metastatic gastric cancer
    • Gastric cancer
    Investigated drugs:
    • Zolbetuximab
    • Capecitabine
    • Folinic Acid
    Belgium Czechia France Germany Italy Lithuania +5

  • Study comparing valemetostat tosylate plus pembrolizumab versus pembrolizumab alone in patients with advanced non-small cell lung cancer with high PD-L1 expression

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Valemetostat Tosilate
    • Pembrolizumab
    France Italy Spain

  • Long-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial

    Not recruiting

    2 1
    Investigated diseases:
    • Asthmatic crisis
    Investigated drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Bulgaria Czechia Germany Italy Poland Spain

  • Study of cagrilintide for weight reduction in adults with overweight or obesity when combined with lifestyle changes

    Not recruiting

    3 1
    Investigated diseases:
    • Overweight
    • Obesity
    Investigated drugs:
    • Cagrilintide
    France Germany Italy Norway Poland

  • Study of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Meningococcal infection
    Investigated drugs:
    • Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
    • Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
    • Recombinant Neisseria Meningitidis Group B Nada Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
    Finland Italy Spain
Previous Page
1 … 951 952 953 954 955 … 1,616
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!